Ashland Specialty Ingredients, G.P.

Medical device company · Bridgewater, New Jersey, United States

Ashland Specialty Ingredients, G.P. is a medical device company with a registered site in Bridgewater, New Jersey, United States. The US FDA lists 2 medical device sites registered to the company, with devices in radiology and hematology.

Profile compiled from public records. Is this your company? Request a correction or update

Ashland Specialty Ingredients, G.P. at a glance

Typemedical device company
Registered siteBridgewater, New Jersey, United States
FDA-registered sites2

What does Ashland Specialty Ingredients, G.P. do?

Medical specialties of its FDA-listed devices

RadiologyHematology

Device types listed with the FDA

Cassette, radiographic filmInstrument, quality-assurance, radiologicFilm, radiographicAccessory - film dosimetry systemSupplies, blood-bankPhantom, anthropomorphic, radiographic

Where is Ashland Specialty Ingredients, G.P. located?

Registered site: Bridgewater, New Jersey, United States

  • Bridgewater, New JerseyAshland Specialty Ingredients, G.P. · FDA device site
  • Fiskeville, Rhode IslandAshland Specialty Ingredients, G.P. · FDA device site

Frequently asked questions about Ashland Specialty Ingredients, G.P.

Where is Ashland Specialty Ingredients, G.P. based?

Ashland Specialty Ingredients, G.P. is based in Bridgewater, New Jersey, United States.

What does Ashland Specialty Ingredients, G.P. do?

Ashland Specialty Ingredients, G.P. is a medical device company. Its FDA-listed medical devices fall under radiology and hematology.

How many FDA-registered sites does Ashland Specialty Ingredients, G.P. have?

The US FDA lists 2 registered sites for Ashland Specialty Ingredients, G.P..

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences

Ashland Specialty Ingredients, G.P.: Headquarters, Locations & Company Profile (2026) | BioBridgeX